000			01936cam a2200205 a 4500
008			110907s2008 enka b 001 0 eng
020			_a9780199543434
082	0	4	_a338.476 151094 _bHER
100	1		_aHerrmann, Andrea M.
245	1	0	_aOne political economy, one competitive strategy? : _bcomparing pharmaceutical firms in Germany, Italy, and the UK / _cAndrea M. Herrmann.
260			_aOxford ; _aNew York : _bOxford University Press, _c2008.
300			_axvi, 202p. : _bill. ; _c24 cm.
504			_aIncludes bibliographical references and index.
520	1		_a"One Political Economy, One Competitive Strategy? begins with an assessment of how many pharmaceutical firms in Germany, Italy, and the UK pursue strategies facilitated by national institutions governing the financial markets, antitrust activities, and the labour market. Quantitative analyses reveal that deviant firms, competing through institutionally unsupported strategies, outnumber conforming firms by far. Not only does this finding run counter to the expectations of the competitiveness literature, it brings up a whole new line of inquiry. How can firms compete through strategies that are not supported by national institutions? The book addresses this question and illustrates that firms do not necessarily exploit comparative institutional advantages, but that they can also circumvent institutional constraints. International markets and individual collaboration on a contractual basis allow firms to compete despite comparative institutional disadvantages. These findings suggest that trade liberalization does not lead to strategy specialization but to strategy diversification, depending on the inventiveness of entrepreneurs to develop individual approaches to compete."--BOOK JACKET.
650		0	_aPharmaceutical industry
650	1	2	_aDrug Industry
650	2	2	_aEconomic Competition
650	2	2	_aTechnology, Pharmaceutical
942			_2ddc _cBK
999			_c216725 _d216725